In the simplest terms, It isn’t the data. The data has been around for decades and interpreted 100s of thousands if not millions of ways. How the Ai interprets or discovers from the data depends on the data content of the AI datasets and who designed the AI which is at this stage as individual as the persons doing the research. The datasets can be easy to contaminate causing poor results. If a MAbs has a good set AI datasets and keep them that way. AI it can take them a long way. “How do you go from a MAbs company to an AI company?”
ENZC uses AI to identify the immutable sites on viruses. MAbs are then designed to bind to the antigens on these sites. When the viruses are bound to antibody, they are rendered incapable of infecting cells. They will quickly be phagocytized by cells of the immune system. This is the genius of the science. This is the reason that I am holding on to my shares.